Sleep pill could stop Alzheimer's before it starts
NCT ID NCT07213349
Summary
This study is testing whether a sleep medication called daridorexant can help prevent Alzheimer's disease by helping the brain clear harmful proteins linked to the condition. The trial will involve 240 adults who do not have Alzheimer's dementia, regardless of whether they have sleep problems. Participants will take either the medication or a placebo for 12 months to see if it affects biological markers and cognitive performance.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre StoP-Alzheimer (Douglas Mental Health University Institute - Research Centre)
RECRUITINGMontreal, Quebec, H4H 1R3, Canada
Contact
Contact
Conditions
Explore the condition pages connected to this study.